🇺🇸 FDA
Pipeline program

Vaccine PvCS N+C+R

2304-493-26202

Phase 2 mab completed

Quick answer

Vaccine PvCS N+C+R for Malaria is a Phase 2 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Malaria
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials